Literature DB >> 29651120

Myositis: Prognostic factors in 'pneumo-myositis'.

Sonye K Danoff1.   

Abstract

Entities:  

Mesh：

Year:  2018        PMID： 29651120     DOI： 10.1038/nrrheum.2018.55

Source DB:  PubMed          Journal:  Nat Rev Rheumatol        ISSN： 1759-4790            Impact factor:   20.543


× No keyword cloud information.
  7 in total

1.  Assessment of Mortality in Autoimmune Myositis With and Without Associated Interstitial Lung Disease.

Authors:  Cheilonda Johnson; Iago Pinal-Fernandez; Radhika Parikh; Julie Paik; Jemima Albayda; Andrew L Mammen; Lisa Christopher-Stine; Sonye Danoff
Journal:  Lung       Date:  2016-05-11       Impact factor: 2.584

2.  Clinical and pathologic differences in interstitial lung disease based on antisynthetase antibody type.

Authors:  C Johnson; G R Connors; J Oaks; S Han; A Truong; B Richardson; N Lechtzin; A L Mammen; L Casciola-Rosen; L Christopher-Stine; S K Danoff
Journal:  Respir Med       Date:  2014-09-18       Impact factor: 3.415

3.  An official European Respiratory Society/American Thoracic Society research statement: interstitial pneumonia with autoimmune features.

Authors:  Aryeh Fischer; Katerina M Antoniou; Kevin K Brown; Jacques Cadranel; Tamera J Corte; Roland M du Bois; Joyce S Lee; Kevin O Leslie; David A Lynch; Eric L Matteson; Marta Mosca; Imre Noth; Luca Richeldi; Mary E Strek; Jeffrey J Swigris; Athol U Wells; Sterling G West; Harold R Collard; Vincent Cottin
Journal:  Eur Respir J       Date:  2015-07-09       Impact factor: 16.671

4.  A longitudinal cohort study of the anti-synthetase syndrome: increased severity of interstitial lung disease in black patients and patients with anti-PL7 and anti-PL12 autoantibodies.

Authors:  Iago Pinal-Fernandez; Maria Casal-Dominguez; Julio A Huapaya; Jemima Albayda; Julie J Paik; Cheilonda Johnson; Leann Silhan; Lisa Christopher-Stine; Andrew L Mammen; Sonye K Danoff
Journal:  Rheumatology (Oxford)       Date:  2017-06-01       Impact factor: 7.580

5.  Pneumocystis jiroveci pneumonia in rheumatic disease: a 20-year single-centre experience.

Authors:  Christopher A Mecoli; Deanna Saylor; Allan C Gelber; Lisa Christopher-Stine
Journal:  Clin Exp Rheumatol       Date:  2017-01-27       Impact factor: 4.473

6.  Idiopathic inflammatory myositis-associated interstitial lung disease: ethnicity differences and lung function trends in a British cohort.

Authors:  Felix Chua; Alexandra M Higton; Alexandra N Colebatch; Katherine O'Reilly; Sisa Grubnic; Ioannis Vlahos; Christopher J Edwards; Patrick D W Kiely
Journal:  Rheumatology (Oxford)       Date:  2012-07-04       Impact factor: 7.580

7.  The predictive prognostic factors for polymyositis/dermatomyositis-associated interstitial lung disease.

Authors:  Yumiko Sugiyama; Ryusuke Yoshimi; Maasa Tamura; Mitsuhiro Takeno; Yosuke Kunishita; Daiga Kishimoto; Yuji Yoshioka; Kouji Kobayashi; Kaoru Takase-Minegishi; Toshiyuki Watanabe; Naoki Hamada; Hideto Nagai; Naomi Tsuchida; Yutaro Soejima; Hiroto Nakano; Reikou Kamiyama; Takeaki Uehara; Yohei Kirino; Akiko Sekiguchi; Atsushi Ihata; Shigeru Ohno; Shouhei Nagaoka; Hideaki Nakajima
Journal:  Arthritis Res Ther       Date:  2018-01-11       Impact factor: 5.156
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.